Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript March 20, 2024
Rani Therapeutics Holdings, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.33. RANI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Kiki Patel:
Operator: Welcome to Rani Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Conference Call. At this time, all...
